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Introduction
Subarachnoid hemorrhage (SAH) is a type of stroke that occurs after the rupture of a
brain artery into the subarachnoid meningeal space. Symptoms of the stroke include hemiplegia,
slurred speech, loss of motor skills, and one-sided weakness.1 Subarachnoid hemorrhagic strokes
are more fatal than other more common strokes.2 In many cases, patients are also at risk of
complications such as septicemia, headache, stroke, and hydrocephalus.3 Additionally, SAH
patients can have continued vasoconstriction, arterial narrowing, and meningitis complicating
their recovery.4

Fe2+ + H2O2  Fe3+ + OH- + OH

The release of blood into the subarachnoid
Figure 1: Fenton chemistry: radical initiation.

space provides an opportunity for the introduction of
iron-containing compounds to the cerebrospinal fluid (CSF). Highly-reactive free iron can
participate in Fenton reactions, generating free radicals and ultimately reactive oxygen species
(ROS) that may result in tissue damage (Figure 1).5 The relative contribution of ROS production
to brain injury in SAH and whether there is a compensatory up regulation of small molecule
antioxidants within the CSF has been incompletely explored.
Mass-spectroscopy based (MS-based) metabolomics has been used in the past to analyze
and compare small endogenous molecules.6 Liquid chromatography mass spectrometry (LCMS/MS) can separate, detect, and characterize biochemicals (less than 1000Da) based on their
mass-to-charge ratios and retention time.6–8 Hydrophilic interaction liquid chromatography mass
spectrometry (HILC-MS) is one of the primary methods used to detect polar metabolites which
includes amino acids, citric acid cycle intermediates, and other biologically important small
molecules.9 A typical workflow for the acquisition of metabolomics datasets include compound
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detection by LC-MS/MS followed by bioinformatics analysis in order to determine statistically
significant changes between experimental samples. In this study, we use Elements software
(version 1.2.1, Proteome Software, Inc.) to preform automated identifications and statistical
comparisons between metabolites detected in CSF isolated from SAH patients and normal
controls.10
Disturbances of iron metabolism caused by bleeding may directly impact neuronal
function. As in Alzheimer patients, much of the neurodegeneration is due to oxidative stress in
the brain caused by the break down of hemin.11 The same oxidative stress is present with the
degradation of hematin in CSF. When hematin is degraded in the cytosol of the cell, it causes the
release of Fe2+which is then oxidized into Fe3+. The oxidation of the iron produces the radical
hydroxyl groups, which damages proteins and DNA (Figure 1).11 The disruption of these
molecules result in subsequent apoptosis in neuronal cells.12
In this study, we also explored iron toxicity on neuroblastoma cells by using an MTT
assay. The treatment of this cell line with retinoic acid
induces differentiation of the cells into a primary neuronal
phenotype characterized by process extension and the
production of neurotransmitters.13,14 In addition, we utilized
global metabolomics to identify changes in the CSF due to
SAH. We found that treatment of differentiated
neuroblastomas with hematin, an oxidation product of

Figure 2: The structure of hematin.

hemoglobin, resulted in cell death in concentrations higher
than 15.62 μM. Hemin and hematin are porphyrin molecules with very similar structures. In
hemin, the axial ion is chloride. While, in hematin the coordinating ion is an hydroxide ion
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(Figure 2).15 Both iron donors contain a ferric iron at the center. The chloride ion has as higher
affinity for binding oxygen than the hydroxide ion, and hemin is a primary component in the
formation of hemoglobin.16 The higher affinity for binding oxygen primes hemin for oxygen
transport in blood. Hematin has a hydroxide ion that makes it a primary molecule in heme
signaling.17 Previous studies have shown that the iron coordinated in hemin altered the
concentration of iron within cells. Owen et al. found that there is Fenton-chemistry occurring in
the cells following the incubation of astrocytes with iron-containing hemin. They were able to
measure the concentrations of Fe2+ and Fe3+, and found that they were both present in abundance
in the cytoplasm of the cell following iron treatment. The ferric ions were found in greater
concentration with a hemin containing iron treatment than a non-hemin containing iron
treatment. Previous studies found that the cells had a better ability to store iron in ferritin when
it was introduced through a non-hemin containing iron source. 11 These studies provide a
foundation to further examine metal-mediated pathology in SAH.
Methods and Materials
Cell Culture
The SH-SY5Y human neuroblastoma cell line (ATCC CLR-2266) was cultured in a 1:1
mixture of ATCC-formulated Dulbecco’s Modified Eagle Medium (DMEM) and F12 medium
supplemented with 10% fetal bovine serum (FBS) and 1% penicillin streptomycin. The cells
were incubated at 37ºC and 5% CO2. This is in accordance with ATCC guidelines for cell
maintenance. After cells had reached 100% confluency, they were split. Media and trypsinEDTA were warmed to 37ºC in a hot water bath. The media was removed from the T75 plates
and placed in a 50mL falcon tube. 2mL of trypsin-EDTA was added to the T75 flasks. The cells
were treated with trypsin-EDTA for 2 minutes followed by the addition of 3mL of tissue culture

5
medium. All 5 ml of solution was subsequently added to the 50mL Falcon tube. The cell solution
was then centrifuged at 1000 RPM and 4ºC for 10 minutes. After the centrifuge was completed,
all of the solution was removed carefully as to not disturb the pellet. The pellet was then
suspended in at least 2mL of media. The cell solution was then either plated in a T75 for
continued growth, or used for a 96-well plate.
Iron Treatment and Measurement of Cell Viability
Prior to treatment with iron containing compounds, cells were plated at a density of 2.6
x106 cells/well in a final volume of 100 μl and allowed to adhere for twenty-four hours. Porcine
hematin (Sigma- Aldrich, St Louis, MO) was dissolved in DMSO to create a final concentration
of 2 mM. This stock solution was then serially diluted to 1μM concentration solution. Cells were
incubated for an additional twenty-four hours. Following the incubation, Resazurin was added to
each well at 10% of the final well volume. The resazurin was left to incubate for at least two
hours and then the plate was read using the SpectraMax M2 plate reader. The absorbance was
measured at a reference wavelength 690nm. The absorbance at 690nm was subtracted from the
absorbance at 600nm. Fluorescent emission was measured at 590nm.
For differentiating the neuroblastomas, the cells were plated in the same way as
previously described. However, 1μL of retinoic acid was added to each well and allowed to
incubate for twenty-four hours prior to the administration of hematin.
Metabolite Extraction of Cerebrospinal fluid
The institutional review board at the Cleveland Clinic approved the collection and use of
human CSF samples. CSF samples were stored in liquid nitrogen prior to extraction. The
samples were thawed at 4°C and 100μL of the CSF was collected in Eppendorf tubes. 400μL of
4X methanol was added to each of the samples to denature the CSF. Samples were then
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incubated at -20°C for two hours and centrifuged at 18,000 x g at 4°C for twenty minutes. This
process separates the denatured proteins from extracted metabolites. The supernatants were
collected and dried in a CentriVap Concentrator (LACONCO, Kansas, MO, US) at room
temperature. The dried samples were reconstituted for analysis in 200μL of 35% acetonitrile in
water.18 Samples were then analyzed using LC-MS.
HILIC-MS
Resuspended samples were analyzed on a Micro200 LC (Ekisgent, Redwood, CA, USA)
coupled with a HILC column (Luna 3μ NH2 100Å, 150mmx 1.0mm, Phenomenex Torrance, CA,
USA). HILIC employs two different mobile phases of water and acetonitrile respectively. Each
phase contained an addition of 5mM ammonium acetate and 5mM ammonium hydroxide (pH
8.4). Samples were subsequently analyzed with the following gradient: 0 min 98%, 0.5 min 98%,
1 min 95%, 5 min 80%, 6 min 46%, 13 min 14.7%, 17 min 0%, 17.1 min 100%, 23 min 100%.
Following separation, samples were introduced into a 5600+ Triple ToF Mass
Spectrometer (SCIEX, Framingham, MA, USA). Analysis was done in both in positive and
negative mode. Nitrogen (N2) was used as the ion source nebulizer gas (GS1) at 15 psi, the
heater gas (GS2) was set to 20 psi, and the curtain gas (CUR) was set to 25 psi. The
accumulation time was set to 250ms for the precursor ion acquisition. The positive mode used a
+5000 V ion spray voltage and a +100 V declustering potential (DP). Fragmentation data was
collected using a collision energy spread (CES) of +(20-80) V under positive mode. For negative
mode, data was collected using CES of -(20-80) V.
Elements for Metabolic software (version 1.2.1, Proteome Software, Inc.) was used for
data analysis following HILC-MS.19 This software identifies compounds from MS spectra using
a public database. In this case, the NIST library and combined HMDB and NIST endogenous

7
library were used for metabolite selection.20 Pathways were subsequently mapped using
Cytoscape software.21

Results
The goal of these experiments was to determine metabolic alterations associated with
SAH. This was achieved by using in vitro viability testing and LC-MS analysis. It had been
previously proposed that one source of oxidative damage in the brain is the iron-mediated
production of highly reactive radical iron molecules.22 The first task was to identify the
concentration iron-containing hematin becomes toxic for the neural cells. The neuroblastomas
were treated with varying concentrations of porcine hematin. The difficulty came with
determining the concentration of DMSO that the hematin was soluble in, but didn’t result in
unnecessary cell death. Figures 4 and Figures 5 show undifferentiated and differentiated
neuroblastoma cells treated with hematin concentrations dissolved in 30% DMSO in media. In
total, DMSO accounted for 3% of the well volume. There was not a clear dose-response
relationship with respect to hematin-induced cell death. Very low concentrations or high
concentr
ations of
hematin
appeared
to impair
the

Figure 4: Differentiated SH-SY5Y
treated with concentrations of hematin.
Error bars represent standard deviation.

Figure 5: Undifferentiated SH-SY5Y
treated with concentrations of hematin.
Error bars represent standard deviation.
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viability of the cells. However, at 62.5µM and above, there was a consistent loss of viability.
Additionally, the vehicle had some impact on the viability of the cells. As shown in both Figure
4 and Figure 5, there was a loss of viability in cells treated only with 30% DMSO in Media. We
discovered, during the differentiation protocol, that the cells needed to proliferate for a full
twenty-four hours prior to being treated with the retinoic acid. This gives the neuroblastoma cells
an opportunity to adhere to the plate. The standard error bars are large in the differentiated cells,
because the cells were not given this time. However, in both the differentiated and
undifferentiated cells, there was a significant loss in viability at 62.5µM and above.
We next analyzed CSF samples that were collected from healthy patients and patients
who suffered SAH. The two sample groups were analyzed by LC-MS in order to determine
metabolic changes between the two groups. Metabolite and metabolic pathway changes were
explored by using Elements and Cytoscape. In Elements, metabolites that showed a fold change
less than -3 and greater than 3, and that had a p-value less than or equal to 0.25 were selected as
statistically significant due to the small n and the high variability in human samples.
Volcano plots showing statistically significant changes between the patients and controls
are shown in Figures 6 and 7. The volcano plots compare the p-value s to the log fold intensities
in order to determine which metabolites are significantly changed between sample groups.
Positive fold changes signify an up regulation; while, negative fold changes signify a down
regulation of the metabolite. Metabolites that were increased or decreased compared to controls
were researched to determine their origin. Those that are endogenous were examined by using
Cytoscape to map the potential pathway and enzyme interactions. For each metabolite the
corresponding KEGG ID was found and used to create a network pathway in Cytoscape.
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Figure 6: Volcano plot of
the positive mode
comparing control
patients to SAH patients,
made in Elements.

Figure 7: Volcano plot
of the negative mode
comparing control
patients to SAH
patients, made in
elements.
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Figure 8: Pathways demonstrating significant metabolite change based on LC-MS data.
Presqualene diphosphate and 20-Hydroxyl-Leukotriene E4 are both highlighted green
showing significance.

Significant changes were primarily observed when metabolites were analyzed in positive
mode. In patients who have suffered an SAH, there was a down regulation of 20-hydroxyLeukotriene E4. Leukotrienes are lipid metabolites derived from arachidonic acid, an ω-6 fatty
acid, and plays a role in membrane system.23 Arachidonic acid is a major component of the cell
membranes and has been detected in synaptosomes, mitochondria, and microsomes.23 When free
radicals are introduced to the cell it can trigger the peroxidation of arachidonic acid and
subsequent production of pro-inflammatory lipid mediators.24 In patients who suffered a SAH,
we also saw an upregulation of adrenic acid. Many of the phospholipids in the neuronal cell
membranes are comprised of arachidonic and adrenic acid. Adrenic acid is considered to be a
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prothrombotic factor in the brain.25,26 In addition, adrenic acid has been linked to neuro
degeneration. A recent study demonstrated an upregulation of adrenic acid in the grey matter of
Alzheimer patients when compared to control patients.27 We also observed an upregulation of γglutamyl-L-putrescine. This metabolite is part of the putrescine degradation pathway and
putrescine can contribute to the production of the inhibitory neurotransmitter, GABA.28
Therefore, alterations in putrescine levels after SAH may impact the balance between inhibitory
transmitters such as GABA and excitatory neurotransmitters such as glutamate. Finally, the
stroke patients showed an upregulation of testosterone signaling. Testosterone is reduced to 5αdihydrotestosterone (DHT) and estrogens by the enzyme 5α-reductase. The enzyme itself is very
highly concentrated in the myelin membranes.29
Discussion
In this study, we showed that hematin concentrations higher than 15.62 μM induced cell
death in neuronal cell line. In addition, we were able to preliminarily identify metabolic
pathways associated with SAH in CSF samples. Our focus was primarily on testosterone
metabolism, amino acid metabolism, and leukotriene synthesis. In the future, we would like to
confirm the results from our small sample size to a larger set of patients and quantify metabolite
levels with selective reaction monitoring. Additionally, we need to modify the cell culture
conditions to establish the concentration of DMSO that can solubilize the hematin while
effectively measuring cell death. This would allow us to link alterations in CSF with changes in
neuronal function induced by iron overload.
Our focus was to determine how the reactive oxygen species produced during SAH were
impacting the levels of small molecule metabolites. The LC-MS data is limited due to the time
restraints of the project and the number of CSF samples. However, some promising data arose
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out of this experiment. One of the pathways found to be perturbed by SAH was leukotriene
synthesis. Arachidonic acid, the precursor of leukotriene synthesis is often used as an
inflammatory marker in mice.30 20-Hydroxy-Leukotriene E4 is a lipid oxidation product of
leukotriene E4 and is produced in traumatic brain injury. This may contribute to edema after
trauma.31 Adrenic acid has a very similar structure to arachidonic acid and is also a ω -6 fatty
acid and also showed an increase in CSF after SAH.32 Adrenic acid can induce arterial
constriction33 and can induce inflammation in other diseases such as non-alcoholic fatty liver
disease.34 Therefore, the upregulation of this lipid may play a role in promoting post-stroke
inflammation as well as vasocontstriction associated with further injury.
Testosterone metabolism in the brain is integral to the composition of grey matter.35
Multiple cell types, such as neurons, astrocytes and oligodendrocytes, express the capability of
reducing testosterone into various metabolites.29 Estrogens and DHT that are reduced in the brain
participate in remyelinating following neurodegenerative disease such as multiple sclerosis
(MS). DHT has a higher binding affinity than testosterone for brain androgen receptors and has
been shown to work as a remyelinating factor in the absence of testosterone.36 DHT was
discovered to combat the inflammation and demyelination of the spinal cord as MS progresses.36
It is possible that testosterone signaling reduction in the brain is contributing to the increased
inflammation following the SAH.
γ-Glutamyl-L-putrescine upregulation indicates preturbations in polyamine metabolism,
which is linked to both methylation reactions and NO synthesis.37 It is synthesized from the ATP
driven reaction between putrescine and L-glutamate.38 Polyamines can directly influence brain
function by altering the activity of ion channels, and antagonists have been shown to have
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neuroprotective effects during ischemic stroke.39 The functional outcomes of dysregulation
remain to be explored during SAH.
Conclusion
A subarachnoid hemorrhage causes irreversible damage to the brain tissue. The
mechanism by which the tissue is injured is not well characterized. SH-SY5Y cells were used to
mimic neuronal cells and determine iron toxicity. We found that high concentrations of hematin
can be toxic for neuronal cell lines. However, more research is needed to determine the precise
concentration that affects cell viability. LC-MS data was obtained from SAH patients and control
patients. Even with the small patient number we observe alterations in metabolism associated
with SAH. The affected pathways were mapped using the Cytoscape program. This showed a
change in polyamine metabolism, leukotriene level, and testosterone metabolism. The significant
change in the presence of these metabolites could contribute to increased inflammation and
tissue damage in the brain after SAH.
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Safety Considerations
A sterile technique was utilized during cell cultures and handling of biohazardous
materials. This included wearing protective eyewear, gloves, and a sterile hood any time
biohazardous materials were handled. Maintaining a sterile work place also included using
autoclaved items and spraying all items and hood with 70% ethanol prior to experimentation.
Proper lab attire was worn including lab coat, long pants, close-toed shoes, protective eyewear,
and gloves. Chemicals were disposed of in the appropriate waste containers. If there was a need
for chemical disposal or a lab emergency, then UA Environmental Health and Safety was
contacted and able to assist.

